U.S. Poultry Medicine Market Size, Share & Trends Analysis Report 2025-2033 | Shift Towards Antibiotic Alternatives Drives Growth, New Vaccines and Diagnostics Revolutionize Poultry Health Management

Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "U.S. Poultry Medicine Market Size, Share & Trends Analysis Report By Species (Chicken, Turkey, Ducks), By Product (Biologics, Pharmaceuticals), By Disease Type, By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2025 - 2033" report has been added to ResearchAndMarkets.com's offering.

The U.S. poultry medicine market size was estimated at USD 1.83 billion in 2024 and is projected to reach USD 3.11 billion by 2033, growing at a CAGR of 6.20% from 2025 to 2033

The market is continuously growing, driven by high poultry consumption and market value, a shift towards antibiotic alternatives, and technological advancements in poultry healthcare. According to the USDA Economic Research Service, U.S. poultry products dominate both domestic and global meat markets, due to efficient production systems, advanced genetics, ample feed supply, and strong consumer demand. Between 2013 and 2022, broilers accounted for 67% of poultry sales, followed by eggs at 22% and turkeys at 11%, primarily for consumption.



This surge in demand for poultry products directly translates into the need for efficient and sustainable poultry farming practices, necessitating comprehensive healthcare solutions to maintain the health and productivity of poultry flocks. The per capita consumption of poultry, from 2020 to 2024, is illustrated below in the chart:

Growing concerns over antimicrobial resistance have prompted the U.S. poultry industry to reduce antibiotic use. Regulations like the Preservation of Antibiotics for Medical Treatment Act (PAMTA) and the Preventing Antibiotic Resistance Act (PARA) have restricted the use of medically important antibiotics in poultry and livestock.

For decades, antibiotics have been widely used in livestock and poultry, as high-dose treatments for specific infections and as low-dose growth promoters in animal feed. In 2013, around 131,000 tons of antibiotics were used in food animals, a number projected to increase to nearly 200,000 tons by 2030 due to rising global demand. This shift has led to increased demand for alternative health management strategies, such as vaccines, probiotics, and herbal supplements, to ensure poultry health and productivity.

Advancements in veterinary and animal nutrition technologies have significantly impacted the U.S. poultry pharmaceuticals market. The development of new vaccines, diagnostic tools, feed supplements, and other specialized healthcare products has enabled poultry producers to address a wider range of health challenges, improve flock performance, and enhance food safety. These innovations contribute to more efficient and sustainable poultry farming practices.

Why should you buy this report?

• Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
• Competitive Landscape: Explore the market presence of key players worldwide.
• Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
• Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Key Attributes:

Market Dynamics

• Market Driver Analysis
• High poultry consumption and market value
• Shift towards antibiotic alternatives
• Technological advancements in poultry healthcare

Market Restraint Analysis

• Stringent regulatory compliance and approval processes

U.S. Poultry Medicine Market Analysis Tools

• Industry Analysis - Porter's
• PESTEL Analysis

Regulatory Framework

Pricing Analysis

Product Pipeline Analysis

Estimated Poultry Population in U.S., 2024

Competitive Landscape

• Boehringer Ingelheim International GmbH
• Zoetis Services LLC
• Vaxxinova International BV
• Merck & Co., Inc.
• Elanco
• Ceva Sante Animale
• Phibro Animal Health Corporation
• Virbac
• Hipra
• Vetanco
• Kemin Industries, Inc.
  
  • Market Participant Categorization
  • Company Market Position Analysis/ Heat Map Analysis
  • Participant's Overview
  • Financial Performance
  • Product Benchmarking
  • Strategic Initiatives

U.S. Poultry Medicine Market Report Segmentation

Species Outlook (Revenue, USD Million, 2021 - 2033)

• Chicken
• Broiler
• Layer
• Turkey
• Ducks
• Others

Product Outlook (Revenue, USD Million, 2021 - 2033)

• Biologics
• Vaccines
• Modified/ Attenuated Live
• Inactivated (Killed)
• Other Vaccines
• Other Biologics
• Pharmaceuticals
• Parasiticides
• Anti-infectives
• Anti-inflammatory
• Analgesics
• Others
• Medicated Feed Additives

Disease Type Outlook (Revenue, USD Million, 2021 - 2033)

• Newcastle Disease
• Infectious Bronchitis
• Infectious Bursal Disease
• Coccidiosis
• Salmonella
• Marek's Disease
• Others

Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)

• Oral
• Injectable
• Topical
• Others

Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)

• Veterinary Hospitals & Clinics
• E-commerce
• Offline Retail Stores
• Others

For more information about this report visit https://www.researchandmarkets.com/r/stk30v

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• U.S. Poultry Medicine Market